Bio

I got my doctorate in OT from Thomas Jefferson University in 2022, and shortly after I passed the NBCOT started a 2-year postdoctoral fellowship in Patient-Reported Outcomes at Johnson & Johnson (2022-2024). Now I am in a manger role on the PRO team (2024-present), focusing my research on neuropsychiatric and cardiopulmonary conditions. My team develops and implements the clinical outcome assessment (COA) strategy in clinical trials for drugs in late-stage development (phase 2 and phase 3 trials), and conducts quantitative/qualitative research outside of clinical trials to discover what matters most to people living with different health conditions as well as what they would consider a meaningful change in their disease. I'd love to connect with other OT's doing research and learn from your experiences.